Chief Medical Officer at Noom, Dr
One sample report involving a patient, provided by Ro, showed a summary of the insurance coverage, supply availability and estimated copay for each drug, including Wegovy, Ozempic, Eli Lilly's weight loss injection Zepbound and compounded semaglutide, the active ingredient in Novo Nordisk's GLP-1s
FIGURE 2 3 Clinical applications of GLP-1RAs: comprehensive protection through multi-disease risk reduction 3.1 Cardiovascular protection GLP-1RAs confer substantial cardiovascular benefits that extend beyond glycemic control, primarily by reducing the incidence of major adverse cardiovascular events (MACE)
Patients should maintain a symptom diary to identify patterns and triggers, facilitating more informed discussions with their healthcare team about management strategies
For many GLP-1 users, starting with foundational nutrition support and adjusting gradually based on personal needs is a more sustainable approach
This class of medications includes: Ozempic, Wegovy, and Rybelsus (produced by the Novo Nordisk defendants)